Lalitha Koduri, MD
Infectious Disease · Cranston, RINPI 1619922192
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 104 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $640, 5.1 times the $125 reported in 2019.
Across 104 payments — averaging $22.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$419
- Mylan Specialty L.p.$256
- Regeneron Healthcare Solutions, Inc.$171
- Vanda Pharmaceuticals Inc.$160
- Baxter Healthcare$133
- Insmed, Inc.$123
- plus $1K from 26 others
What the payments were for
- Food & beverage$2,359100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 17 | $419 |
| Mylan Specialty L.p. | 13 | $256 |
| Regeneron Healthcare Solutions, Inc. | 8 | $171 |
| Vanda Pharmaceuticals Inc. | 6 | $160 |
| Baxter Healthcare | 6 | $133 |
| Insmed, Inc. | 1 | $123 |
| Philips North America LLC | 6 | $106 |
| Viiv Healthcare Company | 4 | $100 |
| Merck | 3 | $90 |
| GSK | 4 | $80 |
| Jazz Pharmaceuticals Inc. | 3 | $64 |
| Inogen, Inc. | 3 | $64 |
| Grifols USA, LLC | 3 | $63 |
| Sunovion Pharmaceuticals Inc. | 4 | $46 |
| Covis Pharma GmbH | 2 | $43 |
| Paratek Pharmaceuticals, Inc. | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Ultragenyx Pharmaceutical Inc. | 2 | $35 |
| Astellas Pharma US Inc | 1 | $32 |
| Melinta Therapeutics, LLC | 2 | $32 |
| AstraZeneca | 1 | $27 |
| Exact Sciences | 1 | $27 |
| Lilly USA, LLC | 1 | $26 |
| 3b Medical, Inc. | 1 | $26 |
| AbbVie | 1 | $26 |
| Johnson & Johnson | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Gilead | 1 | $20 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
| Scilex Pharmaceuticals Inc. | 1 | $16 |
| Biomerieux Inc | 1 | $15 |
| Medicomp Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Arikayce$123
How this compares
$2,359 in reported general payments places this provider in the 85th percentile of 52 infectious disease providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErtapenemErtapenem Sodium | 12 | $7,561 |
| CeftriaxoneCeftriaxone Sodium | 19 | $3,378 |
| Vancomycin Hcl | 21 | $2,145 |
| Cefazolin Sodium | 15 | $717 |
| Cephalexin | 30 | $238 |
| Levofloxacin | 11 | $160 |
Paid to pharmacies, not to this prescriber.
Other infectious disease in Cranston
- Kenneth MayerProvidence$129K
- Sapna ChowdhryWoonsocket$123K
- Angela CaliendoProvidence$66K
- Karen TashimaProvidence$8K
- Rami KantorProvidence$3K
- Richa TandonProvidence$2K
- Samira Reyes DassumProvidence$2K
- Timothy FlaniganProvidence$2K
- Michelle LallyProvidence$1K
- Michael PoshkusWest Warwick$691
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.